Part of my emotional recovery from schizophrenia came from identifying and addressing my environmental triggers.

Just in time for the holidays, on December 15, 2025, the U.S. Food and Drug Administration (“FDA”) Office of Prescription Drug Promotion (“OPDP”) issued an untitled letter (the “Letter”) to Karuna ...

Negative symptoms of schizophrenia affect motivation, emotion, and daily life. Learn the signs, why they’re often missed, and ...

Olanzapine long-acting injectable (LAI) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation, for a broad patient population 1 Olanzapine LAI is designed ...

Our journalism is only possible with support from you, our readers. The news mainstream media just doesn’t cover. Racial justice journalism since 1909. Dr. Stephanie Eng remembers the night clearly.

Teva announces positive real-world outcomes for UZEDY® and TEV-'749 in schizophrenia treatment, highlighting improved adherence and reduced hospital visits. Teva Pharmaceuticals has announced positive ...

ABSTRACT: Schizophrenia is a severe and draining mental disorder with varying socio-economic impacts based on the age of onset. This study compares socio-demographic characteristics, employment status ...

ABSTRACT: Schizophrenia is a severe and draining mental disorder with varying socio-economic impacts based on the age of onset. This study compares socio-demographic characteristics, employment status ...

Currently, the facility is conducting test runs without THC, as Toro has not yet received its full license and lacks actual marijuana plant materials. Northern Kentucky man accused of killing fellow ...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., and Medincell, announced results from the efficacy portion of the Phase 3 Subcutaneous OLAnzapine extended-Release ...

TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the presentation of eight ...